https://biotechmorning.com/news/nih-5-billion-ai-chronic-disease-initiative Biotech Morning en 2026-07-23T14:24:42.427Z The $5 Billion Bet That AI Can Crack Chronic Disease https://biotechmorning.com/news/congress-fda-animal-testing-modernization-act Biotech Morning en 2026-07-23T14:23:53.330Z Congress Just Told the FDA to Stop Requiring Lab Rats https://biotechmorning.com/news/cancer-weapon-switched-sides-oblenio-bio Biotech Morning en 2026-07-23T14:23:03.115Z Cancer's Favorite Weapon Just Switched Sides https://biotechmorning.com/news/ai-built-proteins-molecular-sensors Biotech Morning en 2026-07-23T14:22:02.682Z These AI-Built Proteins Sit Quietly Until They Smell Trouble https://biotechmorning.com/news/pfizer-talzenna-xtandi-priority-review-prostate-cancer Biotech Morning en 2026-07-23T14:21:04.211Z Pfizer's Prostate Cancer Combo Just Got the FDA's Fast Lane https://biotechmorning.com/news/zepbound-cheaper-single-dose-vials-2 Biotech Morning en 2026-07-23T14:20:16.130Z Zepbound Just Got a Secret Back Door to Cheaper Prices https://biotechmorning.com/news/roche-kills-lupus-tce-doubles-down-autoimmune Biotech Morning en 2026-07-23T14:19:26.053Z Roche Just Killed Its Lupus Weapon, Then Said "We're Not Done" https://biotechmorning.com/news/senate-bill-biologic-patent-thickets Biotech Morning en 2026-07-23T14:18:34.571Z The Senate Just Declared War on Pharma's Favorite Legal Trick https://biotechmorning.com/news/fifth-ros1-lung-cancer-drug-fda-approval-zidesamtinib Biotech Morning en 2026-07-23T14:17:41.114Z The Fifth Drug for a Cancer That Hits 2% of Lung Patients https://biotechmorning.com/news/battery-less-brain-implant-ability-neurotech Biotech Morning en 2026-07-22T14:26:53.075Z The Brain Implant That Doesn't Need a Battery https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-cell-therapy Biotech Morning en 2026-07-22T14:26:00.092Z Repligen Just Bought the Company That Keeps Cell Therapies Alive https://biotechmorning.com/news/fda-lost-3000-now-hiring-them-back Biotech Morning en 2026-07-22T14:25:07.995Z The FDA Lost 3,000 People. Now It Wants to Hire Them All Back. https://biotechmorning.com/news/novo-nordisk-sues-eli-lilly-glp1-advertising Biotech Morning en 2026-07-22T14:24:16.792Z Novo Nordisk Just Sued Eli Lilly. Yes, Over a Commercial. https://biotechmorning.com/news/allo-316-allogeneic-car-t-solid-tumor-remissions Biotech Morning en 2026-07-22T14:23:24.640Z The Off-the-Shelf Cancer Killer That Wasn't Supposed to Work https://biotechmorning.com/news/crystalys-gout-drug-dotinurad-series-b Biotech Morning en 2026-07-22T14:22:28.971Z This Gout Drug Already Works in Asia. Now It Wants America. https://biotechmorning.com/news/arpa-h-160m-genetic-medicine-platforms Biotech Morning en 2026-07-22T14:21:40.632Z Uncle Sam Just Bet $160M That Gene Therapy Can Work Like Software https://biotechmorning.com/news/jj-ottava-robotic-surgery-fda-authorization Biotech Morning en 2026-07-22T14:20:43.141Z J&J Just Built a Robot That Hides Under the Operating Table https://biotechmorning.com/news/alzheimers-drug-escaped-waiting-room Biotech Morning en 2026-07-22T14:19:51.054Z The Alzheimer's Drug That Just Escaped the Waiting Room